Bangalore India Bio 2013 will consist of an international trade show, multi-track conference, Bio Partnering sessions, Vision Leadership Series and plenary talks, a CEO Conclave, poster session, Bio Quiz and Bio-Excellence awards. The international conference at BIB will focus on parnerting and deal making trends, biosimilars, regenerative medicines, molecular biotechnology and bioinformatics, vaccines and clinical research. This year, there will be two new elements added to the above mentioned programs. BIB will be conducting a workshop that will benefit the young entrepreneurs and will also be having Tele-Plenary Talks from eminent personalities from the world, who will connect through video and tele conferencing.

When BioSpectrum highlighted the fact that enrollment in the biotechnology-related courses has declined this year, Dr Kiran Mazumdar-Shaw responded by saying that "Previously, the curriculum that was taught in institutions did not meet the industry expectation. This has led to the emergence of a vicious cycle of industry not taking in the graduates and students not applying to biotechnology-related courses. We have broken this cycle through the BT Finishing schools, where we have done course correction and the courses are now tailor-made according to what the industry requires."

It is expected that more than 700 delegates, 100 renowned speakers from India and abroad and more than 100 exhibitors will participate and many memorandum of understanding (MoUs), technical tie-ups and business collaborations will be signed during the three-day Bangalore India Bio 2013 event.